Skip to content
Home/Companies/MedTech/HemoCue

HemoCue

MedTech·Sweden·Exited 2007·Held 8yr
Entry
1999
Hold
8yr
Exit
2007

Who owns HemoCue?

HemoCue is a Swedish MedTech company, now owned by Quest Diagnostics, which acquired it in 2007 from EQT.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
EQT
Investor
EQT
EQT I · 1994 · Buyout

Key facts

HQSweden
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
Quest Diagnostics
Exit Year
2007

More from EQT I

Other portfolio companies in the same fund.

Thule
Exited 2004
ConsumerSweden· 1999
to Candover
Ballingslov
Exited 2002
ConsumerSweden· 1998
Struers
Exited 2001
IndustrialsDenmark· 1998
to Roper Industries Inc.
TAC
TAC
Exited 2003
SaaSSweden· 1998
to Schneider Electric
FlexLink
Exited 2005
IndustrialsSweden· 1997
to ABN AMRO Capital
Orrefors Kosta Boda
Exited 1998
ConsumerSweden· 1996
to Royal Scandinavia

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns HemoCue?

HemoCue is now owned by Quest Diagnostics, which acquired it in 2007 from EQT.

When did Quest Diagnostics acquire HemoCue?

Quest Diagnostics acquired HemoCue in 2007, buying from EQT.

Who did HemoCue sell to?

EQT sold HemoCue to Quest Diagnostics in 2007 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue